Titration Guide: Finding Your Minimum Effective Dose of Medical Cannabis

Why Titration Matters in Cannabis Medicine

• Cannabis is unusual as a medicine in that the dose-response relationship is not always linear; higher doses do not always produce better outcomes
• THC in particular displays a biphasic dose-response for anxiety — low doses reduce anxiety while high doses can trigger or worsen it
• The minimum effective dose (MED) is the lowest dose that achieves the desired therapeutic outcome without unacceptable side effects
• Starting at a low dose and increasing gradually is both safer and more likely to identify the MED than starting at a fixed standard dose

Titration is not simply a cautious approach to cannabis prescribing — it is the most evidence-based method for achieving optimal therapeutic outcomes while minimising adverse effects and cost.

The Standard Titration Protocol

• Most UK specialist prescribers begin with a starting dose of 2.5mg THC per administration, or 5-10mg CBD if prescribing a CBD-dominant product
• Doses are typically increased every three to seven days, allowing sufficient time to assess tolerability and clinical response at each level
• Titration should be recorded in a patient diary tracking symptom severity, dose, time of administration, and side effects
• The target titration period is usually four to eight weeks, after which the prescriber reviews progress and adjusts the regimen

A structured titration protocol not only identifies the optimal dose more accurately but also generates the documentation needed for subsequent review appointments and, if necessary, dose escalation justification.

Factors That Influence Your Optimal Dose

• Body weight has some but not a dominant influence on cannabis pharmacokinetics; the correlation between weight and optimal dose is weaker than for many pharmaceutical drugs
• Endocannabinoid system tone varies between individuals and is influenced by genetics, prior cannabis exposure, stress levels, and diet
• The condition being treated significantly affects the optimal dose; neuropathic pain typically requires higher doses than anxiety or sleep disorders
• The route of administration profoundly affects dose requirements; inhaled cannabis has around 30-50% bioavailability compared to less than 10% for oral preparations

Individual variation in cannabis response is substantial enough that population-level dosing guidelines are merely starting points; the titration process is how each patient finds their personal optimum.

Signs You Have Found Your MED

• Symptom improvement reaches a plateau and does not increase significantly with the next dose increment
• Side effects (dizziness, increased heart rate, drowsiness) are absent or easily tolerated at the current dose
• The patient can carry out their normal daily activities without significant impairment of cognition or motor function
• Sleep, mood, and quality of life measures show objective improvement on validated patient-reported outcome tools

The minimum effective dose is not a fixed endpoint but a dynamic target that may need periodic reassessment as tolerance develops, the underlying condition changes, or the patient’s life circumstances evolve.